Prediction Models for Two Year Overall Survival and Amputation Free Survival After Revascularisation for Chronic Limb Threatening Ischaemia.


Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
10 2022
Historique:
received: 25 12 2021
revised: 27 03 2022
accepted: 29 05 2022
pubmed: 10 6 2022
medline: 16 11 2022
entrez: 9 6 2022
Statut: ppublish

Résumé

The aim of this study was to create prediction models for two year overall survival (OS) and amputation free survival (AFS) after revascularisation in patients with chronic limb threatening ischaemia (CLTI). This was a retrospective analysis of prospectively collected multicentre registry data (JAPAN Critical Limb Ischaemia Database; JCLIMB). Data from 3 505 unique patients with CLTI who had undergone revascularisation from 2013 to 2017 were extracted from the JCLIMB for the analysis. The cohort was randomly divided into development (2 861 patients) and validation cohorts (644 patients). In the development cohort, multivariable risk models were constructed to predict two year OS and AFS using Cox proportional hazard regression analysis. These models were applied to the validation cohort and their performances were evaluated using Harrell's C index and calibration plots. Kaplan-Meier estimates of two year OS and AFS post-revascularisation in the whole cohort were 69% and 62%, respectively. Strong predictors for OS consisted of age, activity, malignant neoplasm, chronic kidney disease (CKD), congestive heart failure (CHF), geriatric nutritional risk index (GNRI), and sex. Strong predictors for AFS included age, activity, malignant neoplasm, CKD, CHF, GNRI, body temperature, white blood cells, urgent revascularisation procedure, and sex. Prediction models for two year OS and AFS showed good discrimination with Harrell's C indexes of 0.73 (95% confidence interval [CI] 0.69 - 0.77) and 0.72 (95% CI 0.68 - 0.76), respectively CONCLUSION: Prediction models for two year OS and AFS post-revascularisation in patients with CLTI were created. They can assist in determining treatment strategies and serve as risk adjustment modalities for quality benchmarking for revascularisation in patients with CLTI at each facility.

Identifiants

pubmed: 35680042
pii: S1078-5884(22)00340-9
doi: 10.1016/j.ejvs.2022.05.038
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

367-376

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2022 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Auteurs

Tetsuro Miyata (T)

Office of Medical Education, School of Medicine, International University of Health and Welfare, Chiba, Japan. Electronic address: tmiyata29@gmail.com.

Hiraku Kumamaru (H)

Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Shinsuke Mii (S)

Department of Vascular Surgery, Saiseikai Yahata General Hospital, Fukuoka, Japan.

Naoko Kinukawa (N)

Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Hiroaki Miyata (H)

Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Kunihiro Shigematsu (K)

Department of Vascular Surgery, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.

Nobuyoshi Azuma (N)

Department of Vascular Surgery, Asahikawa Medical University Hospital, Hokkaido, Japan.

Atsuhisa Ishida (A)

Department of Surgery, Kawasaki Medical School General Medical Centre, Okayama, Japan.

Yuichi Izumi (Y)

Department of Cardiovascular Surgery, Nayoro City General Hospital, Hokkaido, Japan.

Yoshinori Inoue (Y)

Ambulatory Vascular Surgical Clinic Tokyo, Tokyo, Japan.

Hisashi Uchida (H)

Department of Cardiovascular Surgery, Sapporo Kousei Hospital, Hokkaido, Japan.

Takao Ohki (T)

Department of Vascular Surgery, The Jikei University Hospital, Tokyo, Japan.

Sosei Kuma (S)

Department of Vascular Surgery, Kyushu Central Hospital, Fukuoka, Japan.

Koji Kurosawa (K)

Department of Vascular Surgery, Atsugi City Hospital, Kanagawa, Japan.

Akio Kodama (A)

Division of Vascular and Endovascular Surgery, Department of Surgery, Nagoya University Graduate School of Medicine, Aichi, Japan.

Hiroyoshi Komai (H)

Department of Vascular Surgery, Kansai Medical University Medical Centre, Osaka, Japan.

Kimihiro Komori (K)

Division of Vascular and Endovascular Surgery, Department of Surgery, Nagoya University Graduate School of Medicine, Aichi, Japan.

Takashi Shibuya (T)

Department of Cardiovascular Surgery, Osaka University Hospital, Osaka, Japan.

Shunya Shindo (S)

Department of Cardiovascular Surgery, Tokyo Medical University, Hachioji Medical Centre, Tokyo, Japan.

Ikuo Sugimoto (I)

Department of Medical Safety Management, Aichi Medical University, Aichi, Japan.

Juno Deguchi (J)

Department of Vascular Surgery, Saitama Medical Centre, Saitama Medical University, Saitama, Japan.

Katsuyuki Hoshina (K)

Department of Vascular Surgery, The University of Tokyo Hospital, Tokyo, Japan.

Maeda Hideaki (M)

Department of Vascular Surgery, Nihon University Itabashi Hospital, Tokyo, Japan.

Hirofumi Midorikawa (H)

Department of Cardiovascular Surgery, Southern TOHOKU General Hospital, Fukushima, Japan.

Terutoshi Yamaoka (T)

Department of Vascular Surgery, Matsuyama Red Cross Hospital, Ehime, Japan.

Hiroya Yamashita (H)

Department of Vascular Surgery, Kumamoto Rehabilitation Hospital, Kumamoto, Japan.

Yasuhiro Yunoki (Y)

Department of Cardiovascular Surgery, Kawasaki Medical School Hospital, Okayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH